Yes, Those Marble Columns Can Be Distracting | GenomeWeb

From interviews with 26 former and current leaders of R&D sections of pharmaceutical and biotechnology companies, Frank Douglas and his colleagues found six common themes relating to entrepreneurship in pharma that they report in Nature Reviews Drug Discovery.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.